<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-056737</identifier>
<setSpec>0300-2896</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Polymyositis and interstitial lung disease with a favorable response to corticosteroids and methotrexate</dc:title>
<dc:description xml:lang="en">Polymyositis is a rare collagen disease that can involve the lungs. Between 5% and 30% of patients with polymyositis present interstitial lung disease at diagnosis or during the course of disease. Onset is usually insidious and involves dyspnea and nonproductive cough. Several histopathological findings are associated with polymyositis and the most common is nonspecific interstitial pneumonia. The prognosis of interstitial lung disease associated with polymyositis is better than that of idiopathic pulmonary fibrosis, since most patients respond to treatment with corticosteroids and immunosuppressants.         We report the case of a 60-year-old woman with dyspnea and muscle weakness who was diagnosed with polymyositis and interstitial lung disease (radiography indicated possible nonspecific interstitial pneumonia). The patient responded well to prednisone and methotrexate</dc:description>
<dc:creator>García, Asunción</dc:creator>
<dc:creator>Casanova, Álvaro</dc:creator>
<dc:creator>Valenzuela, Claudia</dc:creator>
<dc:creator>Sánchez, Silvia</dc:creator>
<dc:creator>Hoyos, Nieves</dc:creator>
<dc:creator>Girón, Rosa María</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La polimiositis es una colagenopatía rara, que puede afectar al pulmón. Entre un 5 y un 30% de los pacientes con polimiositis presenta una enfermedad pulmonar intersticial en el momento del diagnóstico o durante el curso de la enfermedad. El inicio suele ser insidioso en forma de disnea y tos seca. Son varias las entidades histopatológicas que se asocian a polimiositis, de las cuales la más frecuente es la neumonía intersticial no específica. El pronóstico de la enfermedad pulmonar intersticial difusa asociada a polimiositis es mejor que el de la fibrosis pulmonar idiopática, ya que la mayoría de los pacientes responde al tratamiento con glucocorticoides e inmunodepresores.                 Presentamos el caso clínico de una mujer de 60 años con síntomas de disnea y debilidad muscular, a quien se diagnosticó de polimiositis y enfermedad pulmonar intersticial difusa (posible neumonía intersticial no específica por hallazgos radiológicos), y que mostró buena respuesta al tratamiento con prednisona y metotrexato</dc:description>
<dc:source>Arch Bronconeumol;43(11): 636-639, nov. 2007. ilus</dc:source>
<dc:identifier>ibc-056737</dc:identifier>
<dc:title xml:lang="es">Polimiositis y afectación pulmonar intersticial con buena respuesta a glucocorticoides y metotrexato</dc:title>
<dc:subject>^d24339^s22045</dc:subject>
<dc:subject>^d31333^s22080</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d31333^s22057</dc:subject>
<dc:subject>^d23481^s22045</dc:subject>
<dc:subject>^d31333^s22012</dc:subject>
<dc:subject>^d30612^s22080</dc:subject>
<dc:subject>^d6082^s22073</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d31333^s22016</dc:subject>
<dc:subject>^d31333^s22027</dc:subject>
<dc:subject>^d28169^s22073</dc:subject>
<dc:subject>^d29514^s22012</dc:subject>
<dc:subject>^d30612^s22016</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d11445^s22057</dc:subject>
<dc:subject>^d30612^s22012</dc:subject>
<dc:subject>^d30612^s22067</dc:subject>
<dc:type>article</dc:type>
<dc:date>200711</dc:date>
</metadata>
</record>
</ibecs-document>
